Technology available for licensing

Biomedical

To learn more or to discuss interest in any of these technologies, contact us at (804) 828-5188 or ott@vcu.edu.

Pharmaceuticals and therapeutics Medical Devices Other

 

RAD-25-002F Proteasome Inhibitors & Targeted Protein Degradation
Redirecting adaptive autophagy to enhance cancer therapy

PET-24-020 Cell Signaling Well Culture Plates
Designed to enhance in-vitro studies of cellular communication pathways.

GOL-23-024, 23-038, 24-039 Nasal Cast Models

ZHA-25-027F Non-Antibody Protein Drug Conjugate
New Frontier in Cancer Treatment

20-073 Stent Wash
Streamlining mechanical thrombectomy to save time and money

12-063 Richmond Agitation-Sedation Scale (RASS)PartnerEASY (Express)

12-089 Detecting Segmentation and Fracture in CT Images
A novel method to diagnose traumatic pelvic injuries

12-111 Microstructures of Silk
Renewable materials for tissue engineering scaffolds

14-041 MECO Fixation System
A surgical solution for midfoot arthrodesis

14-089 Palladium Catalysts for C-H Reactions
Improved methods for API synthesis

16-064 Treatment for Drug Addiction
Potent and Selective Mu Opioid Receptor Modulators

17-049 Anatomically Accurate Brain Phantom
Experimental verification for neuromodulation

17-074 High-Efficiency Delivery of Aerosols to Infants
A more effective method for aerosol delivery

17-075F Capillary-Based Dry Powder Inhaler
Improving the delivery of pharmaceutical aerosols

17-104,18-107 Coupling Catalyst
Highly Active Graphene Based Palladium Catalysts

18-01 Predicting Preterm Birth
Vaginal microbiome composition in early pregnancy

18-019 Synthesizing Hydroxychloroquine
A high-yielding semi-continuous flow method

18-088 Single-Molecule Sensors
Quantitative and simultaneous detection of biomarkers

18-094 Opioid Receptor Modulators
Novel chemicals for treatment of drug use disorder

18-119 Refrigerated Medicine Storage
Optimized for security and temperature monitoring

18-125 Biodegradable polymeric drugs
Repeating units of chemotherapeutic agents

19-026, 19-038 Targeted Immunotherapy
IGFBP-3R agonistic monoclonal antibodies as a mono- or combinational therapy to treat cancer

19-080F Corneal Permeable Anti-Glaucoma Drug
Water soluble, biocompatible pilocarpine analog for treatment of angle-closure glaucoma

19-092 Underslung load stabilization
Stabilizing underslung loads for unmanned aerial vehicle delivery

20-005F & 20-006F Positive pressure inline dry powder inhalers
High efficiency aerosol delivery for infants & children

20-012 Dynamic FRET-based Sensors
Ultrasensitive detection of nucleic acids biomarkers

20-022 Recombinant Chimeric Proteins & Panels
A novel diagnosis of Lyme Disease

20-030 Novel SARS-CoV-2 Treatment
ACE2 Decoy Peptide to Prevent Spike Protein Binding

20-032 Novel Drug Delivery Method for Immunotherapy Treatment
Delivery of Potent STING Activating Nanovaccine

20-155 Anti-microbial Mask
Protective filtering respirators for foul atmospheres

20-158 The Proxy-Flosser
Improving daily flossing for people with braces

20-161 microRNA treatment for traumatic osteoarthritis
Inhibiting miRNAs to prevent and treat OA and other inflammatory diseases

21-013 Novel Minimal Circular RNA
Minimal Circular RNA for Vaccine and Therapeutic Use

21-014 Novel cGAS Therapeutic
Small molecular degrader of Cyclic GMP-AMP synthase

16-033, 21-016 Microfluidic Device for Optical Sorting of Heterogeneous Cell Samples
A modular chipset to enhance the speed and reliability of cell separation by optical trapping

20-160 Cancer Immune Checkpoint Blockade Prognostic
Novel Immune Checkpoint Blockade PD-L1 Quantification

20-048F Native Cell Membrane Polymer Nanoparticles
Novel Molecules for Protein Isolation and Drug Discovery

20-086 Novel Canine Chiimeritope Vaccine for Ehrlichiosis
Chimeric Protein for Diagnostic and Therapeutic use for Monocytic Ehrlichiosis

20-086 Novel Human Chiimeritope Vaccine for Ehrlichiosis
Chimeric Protein for Diagnostic and Therapeutic use in Monocytic Ehrlichiosis

19-108 Reducing Alcohol Craving
Using fecal matter transplant to change gut microbiota

23-005 Targeting E2N for Immuno-Cancer Therapy
Cancer-specific treatment to weaken the cancer cells to improve immunotherapy-induced clearance.

JUD-22-085 Continuity Sensor for Use in Critical Lines and Drains
Detects potentially life-threatening events

KIM-23-095 Automatic Aperture Tracing
An automatic method of aperture tracing in preparing custom cutouts for electron radiation therapy

KIM-23-097 Digital Modulated Radiography
A Novel Approach to Radiography

23-067F Novel ATP and 2,3-BPG Targeting Drug for Sickle Cell Disease Treatment
Lipid particle packaging of PLX small molecules providing localized delivery to treat lung cancers.

22-091 Targeted Allergy and Auto-immune Disease Treatment
Allergen desensitization treatment to reduce or eliminate inflammatory reactions to allergens or auto-immune diseases.

23-024, 23-038, 24-039 Nasal Cast ModelsPartnerSTANDARD (Traditional)
Anatomically Realistic Models for Infants, Children, and Adults

HAD-24-039 Transcranial Magnetic Stimulation (TMS) Coil Design
A novel coil design for TMS with applications in small animals using multi-magnetic materials

SHA-24-049 Positioning Wedge for Fecal Management System (FMS)
Prevents Leaks and Improves Waste Containment